Efficacy of Lactiplantibacillus plantarum 299 and 299v against nosocomial oropharyngeal pathogens in vitro and as an oral prophylactic treatment in a randomized, controlled clinical trial

ConclusionsLp299 and Lp299v inhibited pathogen growth in vitro but did not affect the oropharyngeal microbiota in vivo. The ClinicalTrials.gov Identifier for this study is NCT02303301.

Source: MicrobiologyOpen - February 16, 2021 Category: Microbiology Authors: Anna Tranberg, Bengt Klarin, Julia Johansson, Lisa I. P åhlman Tags: ORIGINAL ARTICLE Source Type: research